Ardsley Advisory Partners’s Axonics, Inc. Common Stock AXNX Stock Holding History

Ardsley Advisory Partners’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-105,000	Closed	-$6.66M	–	174
2021 Q2	$6.66M	Sell	105,000 -20,000	-16%	-$1.18M	0.78%	38
2021 Q1	$7.49M	Sell	125,000 -25,000	-17%	-$1.36M	0.91%	32
2020 Q4	$7.5M	Sell	150,000 -5,000	-3%	-$235K	1.23%	25
2020 Q3	$7.91M	Buy	155,000 +15,000	+11%	+$626K	1.53%	21
2020 Q2	$4.92M	Sell	140,000 -25,000	-15%	-$861K	1.05%	27
2020 Q1	$4.19M	Sell	165,000 -15,500	-9%	-$461K	1.64%	17
2019 Q4	$5M	Buy	+180,500	New	+$4.31M	0.8%	32

Other funds holding AXNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Ardsley Advisory Partners's AXNX Position: Q3 2021 in Review

Ardsley Advisory Partners sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2021, closing a stake of 105,000 shares — an estimated $6.66M sold.

Ardsley Advisory Partners first reported a position in AXNX in Q4 2019 and held it in 7 quarters. The position peaked at $7.91M in Q3 2020. 187 funds tracked by Wall St. Rank hold AXNX as of Q3 2021.

Ardsley Advisory Partners reported no remaining Axonics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Ardsley Advisory Partners sold 105,000 Axonics, Inc. Common Stock shares in Q3 2021, an estimated $6.66M.
Ardsley Advisory Partners first reported a position in Axonics, Inc. Common Stock in Q4 2019 and held it in 7 quarters.
Ardsley Advisory Partners's Axonics, Inc. Common Stock position peaked at $7.91M in Q3 2020.
187 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2021.

Based on Ardsley Advisory Partners's 13F filing for Q3 2021, filed 15 Nov 2021.